Diagnosis and Patient follow-up in Viral Hepatitis infections
Viral Hepatitis is a recognized Public Health issue, with Hepatitis B and Hepatitis C representing respectively 400 millions and 170 millions of chronic carriers.
Other viral Hepatitis (A and E) are food-borne acquired and do not induce any chronic disease. They are mostly endemic to developing countries.
When symptomatic, viral hepatitis share a common clinical pattern:
- flu-like symptoms (sickness, nausea, vomiting, anorexia, fatigue)
- followed by jaundice,
- white stools,
- dark urine
Therefore, although patient background can help orient diagnosis, serological testing is used to determine the diagnosis of either Hepatitis A, B, C or E.
Orientation of Serological Testing
- Patient returning from travel to endemic countries -> HAV, HBV (and HEV for India)
- Patient with “at risk” sexual behavior -> HBV and HCV
Download our Clinical Guide
bioMérieux offer for diagnosis and monitoring of viral hepatitis
With a wide range of products from rapid testing to automated serology tests and microplate screening, bioMérieux offers all the solutions required for routine, confirmation testing and patient follow-up.For patient screening:
- Hepatitis A:
- Hepatitis B:
- VIDAS HBsAg Ultra: a “load and go” test for highly sensitive and specific HBs antigen detection. Designed for optimal detection of variant viruses.
- Hepanostika® HBsAg Ultra: microtiter plate for high throughput, sensitive screening.
- VIKIA HBsAg: a convenient, near-patient testing device.
For patient follow-up:
- Hepatitis B:
- The VIDAS HBV panel enables the monitoring and follow-up of each Hepatitis B viral marker characterizing disease stage progression from acute phase to recovery.